Pfizer Inc PFE:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:28 PM EST
43.45quote price arrow down-0.30 (-0.70%)
Volume
12,686,187
52 week range
41.45 - 56.32
Loading...
  • Open43.82
  • Day High43.90
  • Day Low43.25
  • Prev Close43.76
  • 52 Week High56.32
  • 52 Week High Date04/11/22
  • 52 Week Low41.45
  • 52 Week Low Date10/11/22

Key Stats

  • Market Cap243.926B
  • Shares Out5.613B
  • 10 Day Average Volume27.76M
  • Dividend1.64
  • Dividend Yield3.77%
  • Beta0.61
  • YTD % Change-15.12

KEY STATS

  • Open43.82
  • Day High43.90
  • Day Low43.25
  • Prev Close43.76
  • 52 Week High56.32
  • 52 Week High Date04/11/22
  • 52 Week Low41.45
  • 52 Week Low Date10/11/22
  • Market Cap243.926B
  • Shares Out5.613B
  • 10 Day Average Volume27.76M
  • Dividend1.64
  • Dividend Yield3.77%
  • Beta0.61
  • YTD % Change-15.12

RATIOS/PROFITABILITY

  • EPS (TTM)5.47
  • P/E (TTM)7.94
  • Fwd P/E (NTM)11.84
  • EBITDA (TTM)42.308B
  • ROE (TTM)35.91%
  • Revenue (TTM)100.331B
  • Gross Margin (TTM)65.52%
  • Net Margin (TTM)31.30%
  • Debt To Equity (MRQ)39.59%

EVENTS

  • Earnings Date05/01/2023(est)
  • Ex Div Date01/26/2023
  • Div Amount0.41
  • Split Date-
  • Split Factor-

Related Video

Pro Picks: Watch all of Tuesday's big stock calls on CNBC
VIDEO10:0310:03
Pro Picks: Watch all of Tuesday's big stock calls on CNBC

Profile

MORE
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global...
Albert Bourla Ph.D.
Chairman of the Board, Chief Executive Officer
David Denton
Executive Vice President, Chief Financial Officer
Aamir Malik
Executive Vice President, Chief Business Innovation Officer
Lidia Fonseca Ph.D.
Executive Vice President